Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Net revenue	$ 3,200,177	$ 2,970,595	$ 2,454,535
Revenue, Product and Service [Extensible Enumeration]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]
Grant income	$ 0	$ 0	$ 10,595
Costs and expenses:
Cost of net revenue	$ 2,720,613	$ 2,553,169	$ 2,008,925
Cost, Product and Service [Extensible Enumeration]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]
General and administrative expenses	$ 190,091	$ 162,125	$ 167,505
Depreciation and amortization, excluding patient equipment depreciation	57,087	64,890	63,095
Goodwill impairment (note 5)	830,787	0	0
Total costs and expenses	3,798,578	2,780,184	2,239,525
Operating (loss) income	(598,401)	190,411	225,605
Interest expense, net	130,299	109,414	95,195
Change in fair value of warrant liability (note 11)	(34,482)	(17,158)	(53,181)
Change in fair value of contingent consideration common shares liability (note 11)	0	0	(29,389)
Loss on extinguishment of debt	0	0	20,189
Other loss, net	29,566	253	1,832
(Loss) income before income taxes	(723,784)	97,902	190,959
Income tax (benefit) expense	(49,004)	24,769	32,806
Net (loss) income	(674,780)	73,133	158,153
Income attributable to noncontrolling interest	4,115	3,817	1,978
Net (loss) income attributable to AdaptHealth Corp.	$ (678,895)	$ 69,316	$ 156,175
Weighted average common shares outstanding - basic (in shares)	134,156	134,175	126,306
Weighted average common shares outstanding - diluted (in shares)	134,418	138,988	133,034
Basic net income (loss) per share (note 12) (in dollars per share)	$ (5.06)	$ 0.47	$ 1.12
Diluted net income (loss) per share (note 12) (in dollars per share)	$ (5.31)	$ 0.33	$ 0.67